Oncotelic Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-07-22.
Oncotelic Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on July 22, 2026. The filing reports $712K sold. Its industry group is Biotechnology. It names VUONG TRIEU (Executive Officer, Director), STEVEN KING (Director), ANTHONY MAIDA (Executive Officer, Director) (SEC Form D, July 22, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Oncotelic Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-07-22 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Oncotelic Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Oncotelic Therapeutics, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in July 2026, largest first.
Get an email when Oncotelic Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Oncotelic Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Oncotelic Therapeutics, Inc. →Get the full cited report on Oncotelic Therapeutics, Inc.
What the filing shows about Oncotelic Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Oncotelic Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Oncotelic Therapeutics, Inc.'s address as 29397 Agoura Road, Suite 107, Agoura Hills, CA 91301.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Oncotelic Therapeutics, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Oncotelic Therapeutics, Inc. See pricing
Oncotelic Therapeutics, Inc. is a registered filer with the SEC (CIK 908259) and has filed since 2023-07-13. 3 filings are on record, the latest on 2026-07-22.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Oncotelic Therapeutics, Inc.'s Form D of 2026-07-22 names Vuong Trieu, Steven King, Anthony Maida and 3 more as its officers, directors or promoters.
Its new offerings report $987K sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $712K, on the same scale — one filing against the whole group's total, so it sits low by construction.
RSUs, CONVERTIBLE INTO CONV. SERIES A PREF. SHARES, THEN INTO COMMON STOCK. GRANTED TO D&Os, EMPOYEES AND ADVISORS FOR SERVICES TO THE COMPANY. RSUs ARE CONTINGENT UPON ACHIEVEMENT OF CERTAIN CORPORATE MILESTONES
Vuong Trieu is named as Executive Officer and Director on the Form D that Oncotelic Therapeutics, Inc. filed with the SEC on 22 July 2026, one of 6 people that filing names.
Steven King is named as Director on the Form D that Oncotelic Therapeutics, Inc. filed with the SEC on 22 July 2026, one of 6 people that filing names.
Anthony Maida is named as Executive Officer and Director on the Form D that Oncotelic Therapeutics, Inc. filed with the SEC on 22 July 2026, one of 6 people that filing names.
Shah Amit is named as Executive Officer on the Form D that Oncotelic Therapeutics, Inc. filed with the SEC on 22 July 2026, one of 6 people that filing names.
Seymour Fein is named as Executive Officer on the Form D that Oncotelic Therapeutics, Inc. filed with the SEC on 22 July 2026, one of 6 people that filing names.
Saran Saund is named as Executive Officer on the Form D that Oncotelic Therapeutics, Inc. filed with the SEC on 22 July 2026, one of 6 people that filing names.
6 people named on the filing — 5 holding an executive role and 1 as a director only.
Named as of the 2026-07-22 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Oncotelic Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Oncotelic Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Oncotelic Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Oncotelic Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Oncotelic Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Oncotelic Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: The rest of the US raises, week of 2026-07-20 · Biotech raises, week of 2026-07-20
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/oncotelic-therapeutics-inc-form-d-26000001